Zusammenfassung
Eine der wesentlichen Gründe für die Morbidität bei Tumorpatienten ist das häufige Auftreten von Nebenwirkungen am Zentralnervensystem (ZNS). Diese werden mit der Magnetresonanztomographie (MRT) sehr sensitiv erfasst und finden sich sowohl bei Therapien von ZNS-Tumoren als auch bei systemischen Therapieansätzen wie der Ganzkörperbestrahlung oder der Chemotherapie von Tumoren des Körperstamms. Durch die deutliche Verlängerung der Überlebenszeit von Tumorpatienten werden sie auch häufiger beobachtet.
Die Arbeit beschreibt die häufigsten akuten und chronischen Veränderungen am ZNS und deren bildmorphologische Korrelate. Akute Veränderungen sind oft reversibel, chronische Veränderungen können bis zu mehrere Jahre nach Abschluss der Therapie beobachtet werden. Therapiebedingte Veränderungen sind sehr schwer von tumorbedingten Veränderungen abgrenzbar, wobei moderne Bildgebungsverfahren wie die MR-Spektroskopie und die MR-Perfusion wichtige differenzialdiagnostische Beiträge liefern.
Abstract
Therapy-related side effects, which are detectable with magnetic resonance imaging (MRI) at high sensitivity, are one of the most frequent causes of morbidity in cancer patients. They can be observed in the treatment of central nervous system (CNS) diseases as well as in systemic therapy, including whole brain irradiation and chemotherapy and are more often seen due to the better overall survival. This review describes the most frequent acute and chronic therapy-related changes in the CNS and the imaging findings. Acute changes are often reversible while chronic changes can be observed up to several years after treatment.
The differentiation of treatment-related from tumor-related changes might be very difficult, although modern imaging modalities such as MR spectroscopy or MR perfusion measurements supply helpful differential diagnostic information.
Literatur
Verdeccia A, Baili P, Quadiglia A et al (2008) Patient survival fo all cancer combined as indicator of cancer control in Europe. Eur J Public Health 18:527–532
Herrlinger U, Steinbach JP (2010) Neurological complications of neurooncological therapy. Nervenarzt 81:940–949
Ricard D, Taillia H, Renard JL (2009) Brain damage from anticancer treatments in adult. Curr Opin Oncol 13:1285–1295
Filley CM (1999) Toxic leucencephalopathy. Clin Neuropharmacol 22:1411–1228
Brown MS, Stemmer SM, Simon JH et al (1998) White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. Am J Neuroradiol 19:217–221
Perry A, Schmidt RE (2006) Cancer therapy associated CNS neuropathy: an update and review of the literature. Acta Neuropathol 111:197–212
Kumar AJ, Leeds NE, Fuller GN et al (2000) Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy induced necrosis of the brain after treatment. Radiology 217:377–384
Hertzberg H, Huk WJ, Ueberall MA et al (1997) CNS late effects after ALL therapy in childhood. Med Pediatr Oncol 28:387–400
Moretti R, Torre P, Antonello RM et al (2005) Neuropschological evaluation of late-onset post radiotherapy encephalopathy: a comparison with vascular dementia. J Neurol Sci 30:195–200
Tilly H, Lepage E, Coiffier B et al (2003) Intensive coneventiaon chemotherapy (ACVBP) compared with standard CHOP for poo prognosis agressive non-Hodgkin lymphoma. Blood 102:4284–4289
Winocur G, VardyJ, Binns MA et al (2006) The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacol Biochem Behav 85:66–75
Gavrilovic IT, Hormigo A, Yahalom J et al (2006) Long-term follow-up of high-dose methotrexate-based therapywith and without whole brain iradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol 24:4570–4574
Wong CS, Van der Kogel AJ (2004) Mechanisms of radiation intory tot he central nervous system: implications for neuroprotection. Mol Interv 4:273–284
Faithfull S, Brada M (1998) Somnolence syndrome in addults following cranial irradiation for primary brain tumors. Clin Cocol 10:250–254
Dietrich J (2010) Chemotherapy associated central nervous system damage. Adv Exp Med Biol 30:296–310
Reinhardt D, Thiele C, Creutzing U (2002) Neuropsychological sequelae in children with AML treated with or without phrophylactic CNS irradiation. Klein Padiatr 214:22–29
Atkinson S, Li Y, Wong CS (2003) Changes in oligodendrocytes and myelin gene expression after irradiation in the rodent spinal cord. Int J Radiat Oncol Biol Phys 57:1093–1100
Morris B, Partap S, Yeom K et al (2009) Cerebrovascular disease in childhood cancer survivors: a children’s oncology group report. Neurology 73:1906–1913
Vaszquez E, Lucaya J, Castellote A et al (2002) Neuroimaging in pediatric leukemia and lymphoma: differential diagnosis. Radiographics 22:1411–1428
Dietrich J, Marienhagen J, Schalke B et al (2004) Vascular neurotoxicity following chemotherapy with cisplatin, ifosfamide and etoposid. Ann Pharmacother 38:242–246
Elliott MA, Wolf RC, Hook CC et al (2004) Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agen regimens: incidence, risk factors, and possible role of antithrombin. Leuk Lymphoma 45:1545–1549
Bartynski WS (2008) Posterior reversibel encephalopathy syndrome, part 1: fundamental imaging and clinical features. Am J Neuroradiol 29:1036–1042
Glass JP, Hwang TL, Leavens ME et al (1984) Cerebral radiation necorosis following treatment of extracranial malignacies. Cancer 54:1966–1972
Oka M, Terae S, Kobayashi R et al (2003) MRI in methotrexate-related leucencepholopathy: disseminted necrotizizing leukencepholopathy in comparison with mild leukencephalopathy. Neuroradiology 45:493–497
Barajas RF, Chang JS, Segal MR et al (2009) Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility weighted contrast enhance perfusion MR imaging. Radiology 253:486–496
Kerklaan JP, Lycklama A Nijeholt GJ, Wiggenraad RG et al (2011) SMART syndrome: a late reversible complication after radiation therapy for brain tumors. J Neurol 258:1098–1104
Essig M, Giesel F, Stieltjes B, Weber MA (2007) Functional imaging for brain tumors (perfusion, DTI and MR spectroscopy). Radiologe 47:513–517
Keezer MR, Del Maestro R (2009) Radiation-induced cavernous hemangiomas: case report and literature review. Can J Neurol Sci 36:303–310
Heckl S, Achoff A, Kunze S (2002) Radiation-induced cavernous hemangiomas of the brain: a late effect predominantly in children. Cancer 94:3285–3291
Franco DA, Greenberg HS (2001) 5-FU multifocal inflammatory leukencephalopathy and dihydropyrimidine dehydrogenase deficiency. Neurology 56:110–112
Interessenkonflikt
Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Essig, M., Dinkel, J. & Zamecnik, C. Visualisierung von Strahlenfolgen am Zentralnervensystem. Radiologe 52, 229–234 (2012). https://doi.org/10.1007/s00117-011-2197-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00117-011-2197-8
Schlüsselwörter
- Morbidität
- Tumorpatienten
- Magnetresonanztomographie (MRT)
- Bildmorphologische Korrelate
- Überlebenszeitverlängerung